E-viri
Recenzirano
Odprti dostop
-
Cohen, Omri; Ageno, Walter; Farjat, Alfredo E.; Turpie, Alexander G. G.; Weitz, Jeffrey I.; Haas, Sylvia; Goto, Shinya; Goldhaber, Samuel Z.; Angchaisuksiri, Pantep; Gibbs, Harry; MacCallum, Peter; Kayani, Gloria; Schellong, Sebastian; Bounameaux, Henri; Mantovani, Lorenzo G.; Prandoni, Paolo; Kakkar, Ajay K.
Journal of thrombosis and haemostasis, February 2022, Letnik: 20, Številka: 2Journal Article
Background Inferior vena cava (IVC) thrombosis is a rare form of venous thromboembolism (VTE). The optimal treatment strategies and outcomes are unclear in patients with this presentation. Objective We aimed to compare baseline characteristics, treatment patterns and 24‐month outcomes in IVC thrombosis patients (n = 100) with lower extremity deep vein thrombosis (LEDVT) patients (n = 7629). Methods GARFIELD–VTE is a prospective, observational registry of 10 868 patients with objectively diagnosed VTE from 415 sites in 28 countries. Results IVC thrombosis patients were younger (51.9 vs. 59.8 years), more frequently had active cancer (26.0% vs. 8.9%) or history of cancer (21.0% vs. 12.2%), and less frequently had recent trauma or surgery than LEDVT patients. IVC thrombosis was more frequently treated with parenteral anticoagulants alone (35.1% vs. 15.9%), whereas patients with LEDVT more commonly received vitamin K antagonists (32.0% vs. 25.8%) or direct oral anticoagulants (49.0% vs. 35.1%). Thrombolysis (11.0% vs. 3.6%) and surgical/mechanical interventions (4.0% vs. 1.4%) were more frequent in IVC thrombosis. At 24‐months, the rate per 100 person‐years (95% confidence interval) of all‐cause mortality was higher in patients with IVC thrombosis than LEDVT (13.28 8.57–20.58 vs. 4.91 4.55–5.3); the incidence of cancer‐associated mortality was comparable as was the incidence of VTE recurrence (4.11 1.85–9.15 vs. 4.18 3.84–4.55). Major bleeding was slightly higher in IVC thrombosis (2.03 0.66–6.31 vs. 1.66 1.45–1.89). Conclusion In summary, IVC thrombosis patients have higher all‐cause mortality rates than those with LEDVT, a finding only partly attributable to malignancy.
Avtor
Vnos na polico
Trajna povezava
- URL:
Faktor vpliva
Dostop do baze podatkov JCR je dovoljen samo uporabnikom iz Slovenije. Vaš trenutni IP-naslov ni na seznamu dovoljenih za dostop, zato je potrebna avtentikacija z ustreznim računom AAI.
Leto | Faktor vpliva | Izdaja | Kategorija | Razvrstitev | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Baze podatkov, v katerih je revija indeksirana
Ime baze podatkov | Področje | Leto |
---|
Povezave do osebnih bibliografij avtorjev | Povezave do podatkov o raziskovalcih v sistemu SICRIS |
---|
Vir: Osebne bibliografije
in: SICRIS
To gradivo vam je dostopno v celotnem besedilu. Če kljub temu želite naročiti gradivo, kliknite gumb Nadaljuj.